Prelude Capital Management’s Avidity Biosciences RNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,654	Closed	-$629K	–	1357
2024 Q1	$629K	Buy	+24,654	New	+$629K	0.03%	472
2023 Q2	–	Sell	-22,240	Closed	-$341K	–	1210
2023 Q1	$341K	Buy	+22,240	New	+$341K	0.02%	526